Excision BioTherapeutics (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- September 06, 2017
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $10,000,000
Company Info
- Founding Year
- 2015
- Founders
- Kamel Khalili, Ph.D., Thomas Malcolm, Ph.D., Rob Simmons, David Rowe
- Company Description
- Excision BioTherapeutics Inc. is a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment and eradication of life-threatening disease caused by neurotropic viruses.
- Market
- Gene Editing Therapeutics
- Location
- Philadelphia, PA, USA
- Coinvestors
- Artis Ventures